Illumina, Inc. (ILMN)
After hours:
| Previous close | 222.03 |
| Open | 224.92 |
| Bid | 222.70 x 800 |
| Ask | 225.33 x 1100 |
| Day's range | 221.58 - 226.25 |
| 52-week range | 173.45 - 371.16 |
| Volume | |
| Avg. volume | 1,345,736 |
| Market cap | 35.433B |
| Beta (5Y monthly) | 1.13 |
| PE ratio (TTM) | 52.63 |
| EPS (TTM) | 4.28 |
| Earnings date | 03 May 2023 - 08 May 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 234.47 |
- Bloomberg
Illumina, Icahn Fight Intensifies After Negotiation Failed
(Bloomberg) -- Illumina Inc. and activist investor Carl Icahn tried but failed to reach a compromise that would have avoided the public battle over seats on its board, according to a preliminary proxy statement filed by the DNA-sequencing company.Most Read from BloombergTrump to Be Arraigned Early Next Week After Historic Indictment$52 Billion Chipmaking Plan Is Racing Toward Failure$335,000 Pay for ‘AI Whisperer’ Jobs Appears in Red-Hot MarketNew Yorkers Are Moving to These Three Florida Cities
- Financial Times
Illumina chief’s pay nearly doubles ahead of clash with Carl Icahn
Francis deSouza was awarded $26.7mn in total pay last year despite drop in genome sequencer’s market value
- PR Newswire
Illumina Files Preliminary Proxy, Urging Shareholders to Vote for Its Director Nominees and Withhold for Each Icahn Group Nominee
Illumina (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today filed its preliminary proxy statement with the Securities and Exchange Commission, which contains important information for shareholders.
